Hepatic Aminotransferases and Bilirubin Levels During Tocilizumab Treatment of Patients with Rheumatoid Arthritis: Pooled Analysis of Five Phase 3 Clinical Trials

被引：0
|
作者：
Bykerk, Vivian P. [1 ]
Kremer, Joel M. [2 ,3 ]
Keystone, Edward C.
机构：
[1] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[2] Albany Med Coll, Albany, NY 12208 USA
[3] Ctr Rheumatol, Albany, NY 12208 USA
来源：
JOURNAL OF RHEUMATOLOGY | 2009年 / 36卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
97
引用
收藏
页码：2591 / 2591
页数：1
相关论文
共 50 条
  • [21] Long-Term Safety of Rituximab in Rheumatoid Arthritis: Pooled Analysis of Patients in Clinical Trials with up to 9.5 Years of Treatment
    van Vollenhoven, Ronald F.
    Emery, Paul
    Bingham, Clifton O.
    Keystone, Edward
    Fleischmann, Roy M.
    Furst, Daniel E.
    Tyson, Nicola
    Collinson, Neil
    Lehane, Patricia B.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S857 - S857
  • [22] IDENTIFICATION OF SYNOVITIS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL REMISSION DURING THERAPY WITH TOCILIZUMAB
    Panasyuk, E.
    Smirnov, A.
    Fedorenko, E.
    Gavva, T.
    Gubar, E.
    Loginova, E.
    Lukina, G.
    Luchikhina, E.
    Tsvetkova, E.
    Avdeeva, A.
    Alexandrova, E.
    Nasonov, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 508 - 509
  • [23] GASTROINTESTINAL SAFETY OF TOCILIZUMAB: DATA FROM PATIENTS WITH RHEUMATOID ARTHRITIS IN ROCHE CLINICAL TRIALS AND CLINICAL PRACTICE
    Van Vollenhoven, Ronald
    Keystone, Edward
    Furie, Richard
    Blesch, Anne
    Wang, Candace D.
    Curtis, Jeffrey R.
    [J]. RHEUMATOLOGY, 2010, 49 : I103 - I103
  • [24] Clinical efficacy and safety of tocilizumab in the treatment of seropositive rheumatoid arthritis patients in India
    Kumar, Abhishek
    Bhakuni, Darshan
    Shanmuganandan, K.
    Hegde, Arun
    Vasdev, Vivek
    Arjun, M. N.
    Kishore, Kunal
    [J]. INDIAN JOURNAL OF RHEUMATOLOGY, 2020, 15 (04) : 286 - 291
  • [25] LONG-TERM GOLIMUMAB PERSISTENCE: 5-YEAR TREATMENT RETENTION DATA POOLED FROM FIVE PHASE III CLINICAL TRIALS IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS
    Weinstein, C.
    Govoni, M.
    Lin, J.
    Meehan, A.
    Qureshi, Z.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 777 - 778
  • [26] Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials
    Winthrop, Kevin L.
    Nash, Peter
    Yamaoka, Kunihiro
    Mysler, Eduardo
    Khan, Nasser
    Camp, Heidi S.
    Song, Yanna
    Suboticki, Jessica L.
    Curtis, Jeffrey R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (02) : 206 - 213
  • [27] Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
    Cindy L. J. Weinstein
    Alan G. Meehan
    Jianxin Lin
    Steven D. Briscoe
    Marinella Govoni
    [J]. Clinical Rheumatology, 2023, 42 : 3397 - 3405
  • [28] Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
    Weinstein, Cindy L. J.
    Meehan, Alan G.
    Lin, Jianxin
    Briscoe, Steven D.
    Govoni, Marinella
    [J]. CLINICAL RHEUMATOLOGY, 2023, 42 (12) : 3397 - 3405
  • [29] AN INTERIM ANALYSIS OF LONG-TERM EXTENSION TRIALS OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    van Vollenhoven, R. F.
    Smolen, J. S.
    Tony, H. P.
    Codding, C.
    Keystone, E. C.
    Woodworth, T.
    Alecock, E.
    Alten, R.
    [J]. RHEUMATOLOGY, 2009, 48 : I86 - I87
  • [30] SUBCUTANEOUS TOCILIZUMAB MONOTHERAPY OR COMBINED WITH A CSDMARD IN PATIENTS WITH RHEUMATOID ARTHRITIS: TOZURA, A POOLED ANALYSIS OF PHASE IV STUDIES IN 22 COUNTRIES
    Choy, E.
    Caporali, R.
    Xavier, R.
    Fautrel, B.
    Sanmarti, R.
    Bernasconi, C.
    Petho-Schramm, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 847 - 848
12345